Low-Carb vs Mediterranean Diet Effects on Bone Health in Young Type 1 Diabetics
24-week study finds no significant differences in bone turnover markers between dietary approaches in adolescents with diabetes.
Summary
Researchers studied 40 adolescents and young adults with type 1 diabetes to compare how low-carbohydrate versus Mediterranean diets affect bone health markers over 24 weeks. Both groups showed similar, non-significant changes in bone formation and breakdown markers (P1NP and CTX). The low-carb group consumed significantly fewer carbohydrates (86g vs 130g daily) and had lower calcium and magnesium intake, but these differences didn't translate to meaningful bone health impacts. This suggests both dietary approaches may be similarly safe for bone health in young people with diabetes, though longer studies are needed.
Detailed Summary
Type 1 diabetes is associated with impaired bone health, and dietary interventions like low-carbohydrate diets have raised concerns about potential negative effects on bone metabolism due to restricted dairy and nutrient intake. This randomized controlled trial provides the first direct comparison of bone health effects between low-carbohydrate and Mediterranean diets in young people with diabetes.
Researchers randomized 40 participants aged 12-21 years with type 1 diabetes to either a low-carbohydrate diet (50-80g carbs daily, 15-20% carbs, 33% protein, 58% fat) or Mediterranean diet (40-50% carbs, 25% protein, 35% fat) for 24 weeks. They measured bone turnover markers including C-terminal telopeptide (CTX, indicating bone breakdown) and procollagen type 1 N-terminal propeptide (P1NP, indicating bone formation) at baseline and 24 weeks.
The low-carb group successfully reduced carbohydrate intake to a median of 86g daily compared to 130g in the Mediterranean group (p<0.001). However, this came with lower calcium (p=0.035) and magnesium intake (p=0.030), though these differences weren't statistically significant after correction for multiple comparisons. The low-carb group also showed a significant decrease in alkaline phosphatase levels (p=0.009).
Crucially, neither group showed statistically significant changes in bone turnover markers. CTX levels changed from 395 to 423 pg/mL in the low-carb group (p=0.278) and from 357 to 296 pg/mL in the Mediterranean group (p=0.245). P1NP decreased from 95 to 88 ng/mL in the low-carb group (p=0.056) and from 76 to 71 ng/mL in the Mediterranean group (p=0.594). Changes in both groups were well below the clinically significant thresholds of 30% for CTX and 21% for P1NP.
These findings suggest that short-term low-carbohydrate diets may not significantly harm bone health in young people with type 1 diabetes, despite reduced intake of bone-supporting nutrients. However, the 24-week duration limits conclusions about long-term effects, and the small sample size may have missed subtle differences between approaches.
Key Findings
- Low-carb group reduced daily carbohydrate intake to 86g vs 130g in Mediterranean group (p<0.001)
- CTX bone breakdown marker showed non-significant changes: +7% in low-carb vs -17% in Mediterranean group
- P1NP bone formation marker decreased by 7% in low-carb and 7% in Mediterranean group (both non-significant)
- Low-carb group had significantly lower calcium (p=0.035) and magnesium intake (p=0.030)
- Alkaline phosphatase levels decreased significantly in low-carb group (p=0.009)
- No participants exceeded clinically significant bone marker change thresholds (30% for CTX, 21% for P1NP)
- Both dietary approaches showed similar safety profiles for bone health over 24 weeks
Methodology
Open-label randomized controlled trial with 40 participants aged 12-21 years with type 1 diabetes, randomized 1:1 to low-carbohydrate or Mediterranean diet interventions for 24 weeks. Bone turnover markers (CTX and P1NP) measured using chemiluminescence immunoassays with validated performance. Dietary intake assessed via food frequency questionnaires and corroborated with insulin pump data. Statistical analysis used IBM SPSS with appropriate corrections for multiple comparisons.
Study Limitations
The study was limited by its 24-week duration, which may not capture long-term bone health effects, and the small sample size of 40 participants may have been underpowered to detect subtle differences. The open-label design could introduce bias, and the study lacked DEXA scan data to complement bone marker findings. Authors noted that longer studies with larger sample sizes are needed to definitively assess bone health impacts of these dietary interventions.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.